| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2003PNAS..100.9208M |
| P356 | DOI | 10.1073/PNAS.1633590100 |
| P932 | PMC publication ID | 170897 |
| P698 | PubMed publication ID | 12883009 |
| P5875 | ResearchGate publication ID | 6476765 |
| P50 | author | Ferid Murad | Q295999 |
| P2093 | author name string | Emil Martin | |
| Iraida Sharina | |||
| Alexander Kots | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| On the activation of soluble guanylyl cyclase by nitric oxide. | Q24531355 | ||
| Activation of soluble guanylate cyclase by carbon monoxide and nitric oxide: a mechanistic model. | Q30323785 | ||
| Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase | Q30427519 | ||
| NO-independent regulatory site on soluble guanylate cyclase | Q32165040 | ||
| Heme-based sensors in biological systems | Q33606960 | ||
| Biological sensors: More than one way to sense oxygen | Q33652937 | ||
| Studying the structure and regulation of soluble guanylyl cyclase | Q33784325 | ||
| Cellular signaling with nitric oxide and cyclic guanosine monophosphate | Q33858341 | ||
| Guanylyl cyclases and signaling by cyclic GMP. | Q33917038 | ||
| YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components | Q33948966 | ||
| CO sensing and regulation of gene expression by the transcriptional activator CooA. | Q34115896 | ||
| Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase | Q35124292 | ||
| A molecular basis for nitric oxide sensing by soluble guanylate cyclase | Q36774286 | ||
| Human recombinant soluble guanylyl cyclase: expression, purification, and regulation | Q37259340 | ||
| Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine | Q39140610 | ||
| Localization of particulate guanylate cyclase in plasma membranes and microsomes of rat liver | Q40326706 | ||
| Activation of soluble guanylate cyclase causes relaxation of corpus cavernosum tissue: synergism of nitric oxide and YC-1. | Q40735472 | ||
| Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit | Q40799534 | ||
| Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone? | Q40840121 | ||
| Heme ligand replacement reactions of cytochrome P-450. Characterization of the bonding atom of the axial ligand trans to thiolate as oxygen | Q42263374 | ||
| Expression of soluble guanylate cyclase activity requires both enzyme subunits | Q42464263 | ||
| Radioimmunoassay for cyclic nucleotides. I. Preparation of antibodies and iodinated cyclic nucleotides | Q43417658 | ||
| Purification of soluble guanylyl cyclase from bovine lung by a new immunoaffinity chromatographic method | Q43913799 | ||
| Dissociation of nitric oxide from soluble guanylate cyclase | Q46951812 | ||
| Soluble guanylyl cyclase: structure and regulation. | Q52980737 | ||
| A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits. | Q53005214 | ||
| Soluble guanylate cyclase purified from bovine lung contains heme and copper | Q55062277 | ||
| Soluble guanylate cyclase from rat lung exists as a heterodimer | Q69881953 | ||
| Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide | Q70930193 | ||
| Binding of nitric oxide and carbon monoxide to soluble guanylate cyclase as observed with Resonance raman spectroscopy | Q71087376 | ||
| Probing the heme iron coordination structure of pressure-induced cytochrome P420cam | Q71807829 | ||
| Guanylate cyclase from bovine lung. A kinetic analysis of the regulation of the purified soluble enzyme by protoporphyrin IX, heme, and nitrosyl-heme | Q72539436 | ||
| Electron paramagnetic resonance spectral evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase | Q72566480 | ||
| Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states | Q72677054 | ||
| Roles of proximal ligand in heme proteins: replacement of proximal histidine of human myoglobin with cysteine and tyrosine by site-directed mutagenesis as models for P-450, chloroperoxidase, and catalase | Q72940389 | ||
| A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: implications for the YC-1 binding site? | Q73187839 | ||
| Effects of GTP on bound nitric oxide of soluble guanylate cyclase probed by resonance Raman spectroscopy | Q73581647 | ||
| Interaction of soluble guanylate cyclase with YC-1: kinetic and resonance Raman studies | Q73626067 | ||
| Mechanism of YC-1-induced activation of soluble guanylyl cyclase | Q74095219 | ||
| Identification of two important heme site residues (cysteine 75 and histidine 77) in CooA, the CO-sensing transcription factor of Rhodospirillum rubrum | Q74533392 | ||
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 9208-9213 | |
| P577 | publication date | 2003-07-25 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation | |
| P478 | volume | 100 |
| Q34342259 | A high-throughput fluorimetric assay for 2-hydroxyglutarate identifies Zaprinast as a glutaminase inhibitor |
| Q36678534 | Alpha1 soluble guanylyl cyclase (sGC) splice forms as potential regulators of human sGC activity |
| Q35855521 | Aspartate 102 in the heme domain of soluble guanylyl cyclase has a key role in NO activation |
| Q34345769 | CCTeta, a novel soluble guanylyl cyclase-interacting protein |
| Q36424922 | Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in mice |
| Q35776824 | Cobinamides are novel coactivators of nitric oxide receptor that target soluble guanylyl cyclase catalytic domain |
| Q37393910 | Constitutive cyclic GMP accumulation in Arabidopsis thaliana compromises systemic acquired resistance induced by an avirulent pathogen by modulating local signals |
| Q41637594 | Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension. |
| Q35604613 | Dynamic ligand exchange in soluble guanylyl cyclase (sGC): implications for sGC regulation and desensitization |
| Q48349018 | Ferid Murad, MD, PhD: a conversation with the editor. |
| Q100635461 | Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases |
| Q28477878 | Identification of residues in the heme domain of soluble guanylyl cyclase that are important for basal and stimulated catalytic activity |
| Q27677544 | Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes |
| Q37694642 | New conception for the development of hypertension in preeclampsia |
| Q34603164 | Oxygen mediates vascular smooth muscle relaxation in hypoxia |
| Q30440623 | Pyridopyrimidine derivatives as inhibitors of cyclic nucleotide synthesis: Application for treatment of diarrhea |
| Q46633532 | Reactive oxygen species induce tyrosine phosphorylation of and Src kinase recruitment to NO-sensitive guanylyl cyclase |
| Q79150555 | Relationships between heme incorporation, tetramer formation, and catalysis of a heme-regulated phosphodiesterase from Escherichia coli: a study of deletion and site-directed mutants |
| Q35586066 | Restoring soluble guanylyl cyclase expression and function blocks the aggressive course of glioma. |
| Q36603913 | Role of nitric oxide and cGMP in the modulation of vascular contraction induced by angiotensin II and Bay K8644 during ischemia/reperfusion |
| Q54618994 | Role of sulfhydryl-dependent dimerization of soluble guanylyl cyclase in relaxation of porcine coronary artery to nitric oxide. |
| Q46403664 | Soluble guanylyl cyclase activation by HMR-1766 (ataciguat) in cells exposed to oxidative stress |
| Q90079015 | Structural insights into the mechanism of human soluble guanylate cyclase |
| Q38180766 | Structures of soluble guanylate cyclase: implications for regulatory mechanisms and drug development |
| Q37598759 | The G-protein regulator LGN modulates the activity of the NO receptor soluble guanylate cyclase |
| Q34042836 | The fibrate gemfibrozil is a NO- and haem-independent activator of soluble guanylyl cyclase: in vitro studies |
| Q46778119 | The relaxant activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]-pyridazine 1,5,6-trioxide in the mouse corpus cavernosum |
| Q37557818 | YC-1 binding to the β subunit of soluble guanylyl cyclase overcomes allosteric inhibition by the α subunit. |
| Q38228596 | sGC-cGMP signaling: target for anticancer therapy |
Search more.